The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer

David Planchard; Benjamin Besse; Harry J M Groen; Sayed M S Hashemi; Julien Mazieres; Tae Min Kim; Elisabeth Quoix; Pierre-Jean Souquet; Fabrice Barlesi; Christina Baik; Liza Villaruz; Ronan J Kelly; Shirong Zhang; Monique Tan; Eduard Gasal; Libero Santarpia; Bruce E Johnson

The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer

David Planchard
, Benjamin Besse
, Harry J M Groen
, Sayed M S Hashemi
, Julien Mazieres
, Tae Min Kim
, Elisabeth Quoix
, Pierre-Jean Souquet
, Fabrice Barlesi
, Christina Baik
, Liza Villaruz
, Ronan J Kelly
, Shirong Zhang
, Monique Tan
, Eduard Gasal
, Libero Santarpia
, Bruce E Johnson

Research output: Book/Report › Report › Professional

Original language	English
Publication status	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

http://Novartis.medicalcongressposters.com/Default.aspx?doc=17f8c

Cite this

Planchard, D., Besse, B., Groen, H. J. M., Hashemi, S. M. S., Mazieres, J., Kim, T. M., Quoix, E., Souquet, P.-J., Barlesi, F., Baik, C., Villaruz, L., Kelly, R. J., Zhang, S., Tan, M., Gasal, E., Santarpia, L., & Johnson, B. E. (2021). The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer. http://Novartis.medicalcongressposters.com/Default.aspx?doc=17f8c

@book{ffcc5ef54f41410a928b3e6f9295594a,

title = "The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer",

author = "David Planchard and Benjamin Besse and Groen, \{Harry J M\} and Hashemi, \{Sayed M S\} and Julien Mazieres and Kim, \{Tae Min\} and Elisabeth Quoix and Pierre-Jean Souquet and Fabrice Barlesi and Christina Baik and Liza Villaruz and Kelly, \{Ronan J\} and Shirong Zhang and Monique Tan and Eduard Gasal and Libero Santarpia and Johnson, \{Bruce E\}",

year = "2021",

language = "English",

}

Planchard, D, Besse, B, Groen, HJM, Hashemi, SMS, Mazieres, J, Kim, TM, Quoix, E, Souquet, P-J, Barlesi, F, Baik, C, Villaruz, L, Kelly, RJ, Zhang, S, Tan, M, Gasal, E, Santarpia, L & Johnson, BE 2021, The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer. <http://Novartis.medicalcongressposters.com/Default.aspx?doc=17f8c>

TY - BOOK

T1 - The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer

AU - Planchard, David

AU - Besse, Benjamin

AU - Groen, Harry J M

AU - Hashemi, Sayed M S

AU - Mazieres, Julien

AU - Kim, Tae Min

AU - Quoix, Elisabeth

AU - Souquet, Pierre-Jean

AU - Barlesi, Fabrice

AU - Baik, Christina

AU - Villaruz, Liza

AU - Kelly, Ronan J

AU - Zhang, Shirong

AU - Tan, Monique

AU - Gasal, Eduard

AU - Santarpia, Libero

AU - Johnson, Bruce E

PY - 2021

Y1 - 2021

M3 - Report

BT - The Updated Overall Survival and Genomic Analysis from a Single-Arm Phase 2 Study of Dabrafenib plus Trametinib in Patients with BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer

ER -